Use of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid's Surgery

Duke University

Status: Withdrawn

Conditions: Upper Eyelid Surgery

Treatments: Other: 2 mL of lidocaine 2% with epinephrine 1:100,000 without rHuPH20; Drug: Hyaluronidase

Study type: Interventional

Funder types: Other

Identifiers

NCT02059694

Pro00051289

Details and patient eligibility

About

To evaluate the use of recombinant hyaluronidase (rHuPH20) as an adjunctive for local anaesthesia, lidocaine 2% with epinephrine 1:100000, for eyelid surgery.

Full description

Subjects scheduled for bilateral upper eyelid surgery will be recruited from among the patients of the Duke Eye Center. After consent is obtained following full explanation of the research, subjects will be randomly assigned (1:1 ratio) on the day of the surgery to receive local anaesthesia by either with recombinant hyaluronidase (rHuPH20) or without it. Approximately 2 ml of prepared block will be infiltrated in both upper eyelids.

Dilutions (Blocks):

A) 0.5 mL of lidocaine 2% with epinephrine 1:100,000 and 0.5 mL of marcaine 0.75% and 1 mL (150 U) of rHuPH20 for a total of 75 U/ml B) 2 mL of lidocaine 2% with epinephrine 1:100,000 without rHuPH20

Test preparation will be applied subcutaneously in both upper eyelids by injection using a 30-gauge injection needle with the patient in supine position. Every patient will be injected by the same Oculoplastic surgeon.

A Pinprick pain test will be perform 5 minutes after each injection using a sterile "finger stick" needle at three sites of each upper eyelid. These sites include medial, central and lateral portion of each eyelid, approximately 4 mm above the lid margin. The subject will be asked to rate the degree of pain experienced at each site on a scale from 0 (none) to 10 (severe). An average pain score will be calculated for each eyelid. This will help determine if one of the 2 dilutions have a faster anaesthetic effect.

Patients will also be instructed to inform the surgeon of precisely when the pain began and subsided to accurately record the duration of the pain experienced.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

• Inclusion Criteria:
• Capable and willing to provide consent
• Has been scheduled for bilateral upper eyelid surgery
• At least 18 years of age
• Exclusion Criteria:
• Unable or unwilling to give consent
• Previous upper eyelid surgery
• Under 18 years of age

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Single Blind

---

0 participants in 2 patient groups

Hyaluronidase

Experimental group

Description:

Dilutions (Blocks): 0.5 mL of lidocaine 2% with epinephrine 1:100,000 and 0.5 mL of marcaine 0.75% and 1 mL (150 U) of rHuPH20 for a total of 75 U/ml

Treatment:

Drug: Hyaluronidase

Comparitor

Other group

Description:

2 mL of lidocaine 2% with epinephrine 1:100,000 without rHuPH20

Treatment:

Other: 2 mL of lidocaine 2% with epinephrine 1:100,000 without rHuPH20